LARSEUS Trademark

Trademark Overview


On Wednesday, December 12, 2018, a trademark application was filed for LARSEUS with the United States Patent and Trademark Office. The USPTO has given the LARSEUS trademark a serial number of 88226790. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 22, 2022. This trademark is owned by CHIESI FARMACEUTICI S.P.A.. The LARSEUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
larseus

General Information


Serial Number88226790
Word MarkLARSEUS
Filing DateWednesday, December 12, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 22, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
Translation of Words in MarkThe wording "LARSEUS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHIESI FARMACEUTICI S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT

Party NameCHIESI FARMACEUTICI S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT

Trademark Events


Event DateEvent Description
Monday, August 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 22, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 3, 2022SOU EXTENSION 5 GRANTED
Friday, December 17, 2021SOU EXTENSION 5 FILED
Tuesday, December 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 17, 2021SOU TEAS EXTENSION RECEIVED
Friday, July 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 7, 2021SOU EXTENSION 4 GRANTED
Wednesday, July 7, 2021SOU EXTENSION 4 FILED
Wednesday, July 7, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 16, 2020SOU EXTENSION 3 GRANTED
Wednesday, December 16, 2020SOU EXTENSION 3 FILED
Wednesday, December 16, 2020SOU TEAS EXTENSION RECEIVED
Saturday, July 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020SOU EXTENSION 2 GRANTED
Thursday, July 2, 2020SOU EXTENSION 2 FILED
Thursday, July 2, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019SOU EXTENSION 1 GRANTED
Monday, December 9, 2019SOU EXTENSION 1 FILED
Monday, December 9, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 12, 2019ASSIGNED TO LIE
Friday, March 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 15, 2019EXAMINER'S AMENDMENT ENTERED
Friday, March 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 15, 2019EXAMINERS AMENDMENT E-MAILED
Friday, March 15, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, March 11, 2019ASSIGNED TO EXAMINER
Friday, January 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 15, 2018NEW APPLICATION ENTERED